PT1181012E - Valproato intravenoso para tratamento de enxaqueca aguda - Google Patents

Valproato intravenoso para tratamento de enxaqueca aguda

Info

Publication number
PT1181012E
PT1181012E PT00928865T PT00928865T PT1181012E PT 1181012 E PT1181012 E PT 1181012E PT 00928865 T PT00928865 T PT 00928865T PT 00928865 T PT00928865 T PT 00928865T PT 1181012 E PT1181012 E PT 1181012E
Authority
PT
Portugal
Prior art keywords
treatment
acute
valproato
enxaqueca
intravenous
Prior art date
Application number
PT00928865T
Other languages
English (en)
Inventor
Keith R Edwards
Original Assignee
Keith R Edwards
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keith R Edwards filed Critical Keith R Edwards
Publication of PT1181012E publication Critical patent/PT1181012E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
PT00928865T 1999-05-04 2000-05-04 Valproato intravenoso para tratamento de enxaqueca aguda PT1181012E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13241699P 1999-05-04 1999-05-04

Publications (1)

Publication Number Publication Date
PT1181012E true PT1181012E (pt) 2005-02-28

Family

ID=22453956

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00928865T PT1181012E (pt) 1999-05-04 2000-05-04 Valproato intravenoso para tratamento de enxaqueca aguda

Country Status (10)

Country Link
US (2) US7141247B2 (pt)
EP (1) EP1181012B1 (pt)
AT (1) ATE275950T1 (pt)
AU (1) AU4703500A (pt)
CA (1) CA2372806A1 (pt)
DE (1) DE60013811T2 (pt)
DK (1) DK1181012T3 (pt)
ES (1) ES2228521T3 (pt)
PT (1) PT1181012E (pt)
WO (1) WO2000066109A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372806A1 (en) 1999-05-04 2000-11-09 Keith R. Edwards Intravenous valproate for acute treatment of migraine headache
US20050159985A1 (en) * 2003-11-21 2005-07-21 Bertram Carl T. System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
PE20110060A1 (es) 2008-06-23 2011-01-31 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432176A (en) * 1988-11-29 1995-07-11 The John Hopkins University Method of retarding the progression of chronic renal failure
US5102913A (en) 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
US6268396B1 (en) * 1998-06-22 2001-07-31 American Biogenetic Sciences, Inc. Use of valproic acid analog for the treatment and prevention of migraine and affective illness
CA2372806A1 (en) 1999-05-04 2000-11-09 Keith R. Edwards Intravenous valproate for acute treatment of migraine headache

Also Published As

Publication number Publication date
EP1181012A2 (en) 2002-02-27
CA2372806A1 (en) 2000-11-09
DK1181012T3 (da) 2005-01-24
US7141247B2 (en) 2006-11-28
ES2228521T3 (es) 2005-04-16
WO2000066109A2 (en) 2000-11-09
DE60013811T2 (de) 2005-11-17
AU4703500A (en) 2000-11-17
DE60013811D1 (de) 2004-10-21
EP1181012B1 (en) 2004-09-15
US20020156131A1 (en) 2002-10-24
ATE275950T1 (de) 2004-10-15
WO2000066109A3 (en) 2001-02-15
US7163689B2 (en) 2007-01-16
US20050245611A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
PT1181012E (pt) Valproato intravenoso para tratamento de enxaqueca aguda
EP1086702A3 (en) Method for reduction of headache pain
MY132705A (en) Novel compounds with analgesic effect
BR0109703A (pt) Derivados de piperazina
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
NO20021808D0 (no) Substituerte indoler for modulering av NFkB-aktivitet
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
BR0115162A (pt) Tratamentos antitumorais eficazes
ES2170821T3 (es) Aplicacion topica de anestesicos locales para tratar las cefalalgias.
EE200200283A (et) Zolmitriptaani sisaldavad ravimpreparaadid
BR0109515A (pt) Derivados da apomorfina e métodos para seu uso
HUP0105281A2 (hu) Rákellenes hatású benzaldehidszármazékok és gyógyászati alkalmazásuk
NO20022920L (no) Nye forbindelser
MY139368A (en) Novel cyclohexyl sulphones
MD1521F2 (en) Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
KR960704933A (ko) 난치성 동통에 대한 진통제 및 완화제로서의 릴렉신의 용도
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
UA40393A (uk) Спосіб лікування хронічного обструктивного бронхіту
UA26886C2 (uk) Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість